Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers

Pharmacogenetics

Volumn 9, Issue 4, 1999, Pages 533-537

  Jourenkova Mironova, Nadejda ^a   Wikman, Harriet ^b   Bouchardy, Christine ^c   Mitrunen, Katja ^b   Dayer, Pierre ^c   Benhamou, Simone ^a   Hirvonen, Ari ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c GENEVA CANCER REGISTRY   (Switzerland)

Author keywords

Arylamine N acetyltransferase; Disease susceptibility; Genotype; Head and neck neoplasms

Indexed keywords

AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; TOBACCO SMOKE;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARMACOGENETICS; PHARYNX CANCER; PRIORITY JOURNAL; SMOKING;

NICOTIANA TABACUM;

EID: 0032873874     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 1995; 55:5230-5237.
2. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14:1689-1692.
3. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NATI* 10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995; 55:5226-5229.
4. Benhamou S, Bouchardy C, Paoletti C, Dayer P. Effects of CYP2D6 activity and tobacco on larynx cancer risk. Cancer Epidemiol Biomarkers Prev 1996; 5:683-686.
5. Cascorbi I, Brockmoller J. Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996; 56:3961-3966.
6. Deitz AC, Doll MA, Hein DW. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal Biochem 1997; 253:219-224.
7. Doll MA, Jiang W, Deitz AC, Rustan TD, Hein DW. Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem Biophys Res Commun 1997; 233:584-591.
8. Drozdz M, Gierek T, Jendryczko A, Pilch J, Piekarska J. N-acetyltransferase phenotype of patients with cancer of the larynx. Neoplasma 1987; 34:481-484.
9. Gonzalez MV, Alvarez V, Pello MF, Menendez MJ, Suarez C, Coto E. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 1998; 51:294-298.
10. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, et al. Human acetyltransferase polymorphisms. Mutat Res 1997; 376:61-70.
11. Katoh T, Kaneko S, Boissy R, Watson M, Ikemura K, Bell DA. A pilot study testing the association between N-acetyltransferases 1 and 2 risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis 1998; 19:1803-1807.
12. Taylor JA, Umbach DM, Stephens K, Castranio T, Paulson D, Robertson C, et al. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 1998; 58:3603-3610.
13. Vatsis KP, Weber WW. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch Biochem Biophys 1993; 301:71-76.
14. Vincis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 1997; 71:1-3.
15. Zenser TV, Lakshmi VM, Rustan TD, Doll MA, Deitz AC, Davis BB, Hein DW. Human N-acetylation of benzidine: role of NAT1 and NAT2. CanrerRes 1996; 56:3941-3947.